MARIE MASTRANGELO: Open Payments
NPI 1457005001 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 44 payments from 16 companies in 2025. Trend: 2023 $443 · 2024 $1,740 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $210 |
| Novo Nordisk Inc | 10 | $188 |
| ALK-Abello, Inc | 1 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Exact Sciences Corporation | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| ABBVIE INC. | 2 | $41 |
| Insulet Corporation | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $27 |
Products named: Odactra, ZEPBOUND, XIFAXAN, MOUNJARO, Wegovy, Rybelsus, CAPLYTA, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
